Results 201 to 210 of about 2,103,421 (365)
Management Control and Innovative Activity [PDF]
This paper discusses theoretically the different incentives of managers versus firm owners to invest in innovative activities. There are opposing effects concerning R&D intensity in the manager-controlled firm.
Czarnitzki, Dirk, Kraft, Kornelius
core
The Jordanian Stock Market: Should You Invest in it for Risk Diversification or Performance?
Tahsin Saadi-Sedik, Martin Petri
openalex +1 more source
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz +3 more
wiley +1 more source
Investing in Influence: Investors, portfolio firms, and political giving
Eyub Yegen +4 more
openalex +1 more source
Differences in Herding: Individual vs. Institutional Investors
Wei Li, Steven Shuye Wang, Ghon Rhee
openalex +1 more source
DNA strands are employed both as dynamic linkers and nanoscale templates for the integration of Ag2S nanoparticles on MoS2, which in turn imparted photothermal responsiveness; this feature permits the selective cargo (fluorophore, quantum dots or an enzyme) release from the MoS2 surface in response to local heat induced by light irradiation.
Kai Chen +3 more
wiley +1 more source
Systemic Investing for a Regenerative Future: CO_'s Strategy and its Nature to Nurture Initiative
Idongesit Sampson, Jason Jay
openalex +1 more source
Shaping Ti3C2 MXene Nanospheres for Precision Near‐Infrared Photothermal Therapy
In this study, we report producing spherical MXenes via fs laser fragmentation of Ti3C2 flakes in liquid medium. The nanoparticles demonstrated pronounced light absorption and high photothermal conversion efficiencies of 68% and 63% under heating with NIR‐I and NIR‐II lasers, respectively.
Julia S. Babkova +21 more
wiley +1 more source
Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome. [PDF]
Urano F +12 more
europepmc +1 more source

